UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 197

Sortiert nach

Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression

PLoS medicine, 2020-12, Vol.17 (12), p.e1003461

2020

Volltextzugriff (PDF)

Fatty Liver and Chronic Kidney Disease: Novel Mechanistic Insights and Therapeutic Opportunities

Diabetes care, 2016-10, Vol.39 (10), p.1830-1845

2016

Volltextzugriff (PDF)

Molecular Mechanisms of Curcumin in the Pathogenesis of Metabolic Dysfunction Associated Steatotic Liver Disease

Nutrients, 2023-12, Vol.15 (24), p.5053

2023

Volltextzugriff (PDF)

Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma

International journal of molecular sciences, 2019-04, Vol.20 (7), p.1745

2019

Volltextzugriff (PDF)

Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat Load

International journal of molecular sciences, 2016-03, Vol.17 (4), p.479-479

2016

Volltextzugriff (PDF)

TM6SF2 rs58542926 variant affects postprandial lipoprotein metabolism and glucose homeostasis in NAFLD[S]

Journal of lipid research, 2017-06, Vol.58 (6), p.1221-1229

2017

Volltextzugriff (PDF)

Downregulation of inflammatory markers by conjugated linoleic acid isomers in human cultured astrocytes

Nutritional neuroscience, 2019-03, Vol.22 (3), p.207-214

2019

Volltextzugriff (PDF)

Effect of lectin-like oxidized LDL receptor-1 polymorphism on liver disease, glucose homeostasis, and postprandial lipoprotein metabolism in nonalcoholic steatohepatitis

The American journal of clinical nutrition, 2011-10, Vol.94 (4), p.1033-1042

2011

Volltextzugriff (PDF)

Compositional Characteristics and Antioxidant Activity of Edible Rose Flowers and Their Effect on Phenolic Urinary Excretion

Polish journal of food and nutrition sciences, 2021-01, Vol.71 (4), p.383-392

2021

Volltextzugriff (PDF)

Lipidomics in pathogenesis, progression and treatment of nonalcoholic steatohepatitis (NASH): Recent advances

Progress in lipid research, 2023-07, Vol.91, p.101238-101238, Article 101238

2023

Volltextzugriff (PDF)

Emerging Liver–Kidney Interactions in Nonalcoholic Fatty Liver Disease

Trends in molecular medicine, 2015-10, Vol.21 (10), p.645-662

2015

Volltextzugriff (PDF)

Assessing the risk of ketoacidosis due to sodium-glucose cotransporter

PLoS medicine, 2020-12, Vol.17 (12)

2020

Volltextzugriff (PDF)

Effect of phospholipid curcumin Meriva® on liver histology and kidney disease in nonalcoholic steatohepatitis a randomized, double-blind, placebo-controlled trial

Hepatology (Baltimore, Md.), 2024-05

2024

Volltextzugriff (PDF)

Astrocytes shed large membrane vesicles that contain mitochondria, lipid droplets and ATP

Histochemistry and cell biology, 2013-02, Vol.139 (2), p.221-231

2013

Volltextzugriff (PDF)

Advanced glycation end products and their related signaling cascades in adult survivors of childhood Hodgkin lymphoma: A possible role in the onset of late complications

Free radical biology & medicine, 2022-01, Vol.178, p.76-82

2022

Volltextzugriff (PDF)

FRI-314 Plasminogen activator inhibitor-1 (PAI-1) is associated with hepatic steatosis improvement after lifestyle intervention in overweight/obese subjects with metabolic-dysfunction associated steatotic liver disease

Journal of hepatology, 2024-06, Vol.80, p.S501-S502

2024

Volltextzugriff (PDF)

WED-243-YI Irisin level as a potential biomarker for hepatic steatosis improvement after a 6-month lifestyle intervention in patients with metabolic dysfunction-associated steatotic liver disease

Journal of hepatology, 2024-06, Vol.80, p.S525-S525

2024

Volltextzugriff (PDF)

WED-233-YI The single nucleotide polymorphism rs780094 C>T in the glucokinase regulator gene (GCKR) is associated with hepatic steatosis improvement after lifestyle intervention in overweight/obese subjects with metabolic dysfunction-associated steatotic liver disease

Journal of hepatology, 2024-06, Vol.80, p.S522-S522

2024

Volltextzugriff (PDF)

FRI-251-YI Hepatic steatosis contributes to cognitive impairment in patients with metabolic dysfunction-associated steatotic liver disease and/or type 2 diabetes-mellitus

Journal of hepatology, 2024-06, Vol.80, p.S483-S483

2024

Volltextzugriff (PDF)

Angiotensin II Type 1 Receptor rs5186 Gene Variant Predicts Incident NAFLD and Associated Hypertension: Role of Dietary Fat-Induced Pro-Inflammatory Cell Activation

The American journal of gastroenterology, 2019-04, Vol.114 (4), p.607-619

2019

Volltextzugriff (PDF)

Endoscopic duodenal mucosa ablation techniques for diabetes and nonalcoholic fatty liver disease: A systematic review

Med (New York, N.Y. : Online), 2024-07, Vol.5 (7), p.735-758.e2

2024

Volltextzugriff (PDF)

THU-415 - Glucose and lipid metabolism alterations after an oral lipid meal in patients with non-alcoholic fatty liver disease carrying the PNPLA3 rs738409 polymorphism

Journal of hepatology, 2023-06, Vol.78, p.S605-S606

2023

Volltextzugriff (PDF)

Glucose and lipid metabolism alterations after an oral lipid meal in patients with non-alcoholic fatty liver disease carrying the PNPLA3 rs738409 polymorphism

Journal of hepatology, 2023-06, Vol.78, p.S605-S606

2023

Volltextzugriff (PDF)

De novo lipogenesis discriminates advanced hepatic fibrosis after an oral glucose load in non-obese subjects with non-alcoholic fatty liver disease

Journal of hepatology, 2023-06, Vol.78, p.S611-S612

2023

Volltextzugriff (PDF)

THU-425 - De novo lipogenesis discriminates advanced hepatic fibrosis after an oral glucose load in non-obese subjects with non-alcoholic fatty liver disease

Journal of hepatology, 2023-06, Vol.78, p.S611-S612

2023

Volltextzugriff (PDF)

1 – 25 von 197

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(178)
Mit Volltextzugriff
(172)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression

Fatty Liver and Chronic Kidney Disease: Novel Mechanistic Insights and Therapeutic Opportunities

Molecular Mechanisms of Curcumin in the Pathogenesis of Metabolic Dysfunction Associated Steatotic Liver Disease

Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma

Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat Load

TM6SF2 rs58542926 variant affects postprandial lipoprotein metabolism and glucose homeostasis in NAFLD[S]

Downregulation of inflammatory markers by conjugated linoleic acid isomers in human cultured astrocytes

Effect of lectin-like oxidized LDL receptor-1 polymorphism on liver disease, glucose homeostasis, and postprandial lipoprotein metabolism in nonalcoholic steatohepatitis

Compositional Characteristics and Antioxidant Activity of Edible Rose Flowers and Their Effect on Phenolic Urinary Excretion

Lipidomics in pathogenesis, progression and treatment of nonalcoholic steatohepatitis (NASH): Recent advances

Emerging Liver–Kidney Interactions in Nonalcoholic Fatty Liver Disease

Assessing the risk of ketoacidosis due to sodium-glucose cotransporter

Effect of phospholipid curcumin Meriva® on liver histology and kidney disease in nonalcoholic steatohepatitis a randomized, double-blind, placebo-controlled trial

Astrocytes shed large membrane vesicles that contain mitochondria, lipid droplets and ATP

Advanced glycation end products and their related signaling cascades in adult survivors of childhood Hodgkin lymphoma: A possible role in the onset of late complications

FRI-314 Plasminogen activator inhibitor-1 (PAI-1) is associated with hepatic steatosis improvement after lifestyle intervention in overweight/obese subjects with metabolic-dysfunction associated steatotic liver disease

WED-243-YI Irisin level as a potential biomarker for hepatic steatosis improvement after a 6-month lifestyle intervention in patients with metabolic dysfunction-associated steatotic liver disease

WED-233-YI The single nucleotide polymorphism rs780094 C>T in the glucokinase regulator gene (GCKR) is associated with hepatic steatosis improvement after lifestyle intervention in overweight/obese subjects with metabolic dysfunction-associated steatotic liver disease

FRI-251-YI Hepatic steatosis contributes to cognitive impairment in patients with metabolic dysfunction-associated steatotic liver disease and/or type 2 diabetes-mellitus

Angiotensin II Type 1 Receptor rs5186 Gene Variant Predicts Incident NAFLD and Associated Hypertension: Role of Dietary Fat-Induced Pro-Inflammatory Cell Activation

Endoscopic duodenal mucosa ablation techniques for diabetes and nonalcoholic fatty liver disease: A systematic review

THU-415 - Glucose and lipid metabolism alterations after an oral lipid meal in patients with non-alcoholic fatty liver disease carrying the PNPLA3 rs738409 polymorphism

Glucose and lipid metabolism alterations after an oral lipid meal in patients with non-alcoholic fatty liver disease carrying the PNPLA3 rs738409 polymorphism

De novo lipogenesis discriminates advanced hepatic fibrosis after an oral glucose load in non-obese subjects with non-alcoholic fatty liver disease

THU-425 - De novo lipogenesis discriminates advanced hepatic fibrosis after an oral glucose load in non-obese subjects with non-alcoholic fatty liver disease

Suchergebnisse filtern